The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.

作者: Gillian S Dite , Georgia Chenevix-Trench , Amanda B Spurdle , Melissa C Southey , Sarah L Ellis-Steinborner

DOI:

关键词: Family historyMedicineMammary glandMiddle ageOncologyLogistic regressionInternal medicinePopulationConfidence intervalBreast cancerGenotypePathology

摘要: The BRCA2 N372H nonconservative amino acid substitution polymorphism appears to affect fetal survival in a sex-dependent manner, and the HH genotype was found be associated with 1.3-fold risk of breast cancer from pooling five case-control studies Northern European women. We investigated whether Australian women using population-based design. 372 determined 1397 cases under age 60 years at diagnosis first primary 775 population-sampled controls frequency matched for age. Case-control analyses comparisons distributions were conducted logistic regression. All statistical tests two-tailed. independent family history within controls, more common (9.2% versus 6.5%). It an increased cancer, 1.47-fold unadjusted (95% confidence interval, 1.05–2.07; P = 0.02), 1.42-fold 1.00–2.02; 0.05) after adjusting measured factors. This effect still evident excluding any non-Caucasian ancestry or 33 known have inherited mutation BRCA1 , would explain ∼3% cancer. modest recessively result is consistent findings

参考文章(7)
Margaret R.E. McCredie, Gillian S. Dite, Graham G. Giles, John L. Hopper, BREAST CANCER IN AUSTRALIAN WOMEN UNDER THE AGE OF 40 Cancer Causes & Control. ,vol. 9, pp. 189- 198 ,(1998) , 10.1023/A:1008886328352
Catherine S. Healey, Alison M. Dunning, M. Dawn Teare, Diana Chase, Louise Parker, John Burn, Jenny Chang-Claude, Arto Mannermaa, Vesa Kataja, David G. Huntsman, Paul D.P. Pharoah, Robert N. Luben, Douglas F. Easton, Bruce A.J. Ponder, A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nature Genetics. ,vol. 26, pp. 362- 364 ,(2000) , 10.1038/81691
J.L. Hopper, G.G. Giles, M.R.E. McCredie, P. Boyle, Background, rationale and protocol for a case-control-family study of breast cancer The Breast. ,vol. 3, pp. 79- 86 ,(1994) , 10.1016/0960-9776(94)90003-5
M C Southey, A A Tesoriero, C R Andersen, K M Jennings, S M Brown, G S Dite, M A Jenkins, R H Osborne, J A Maskiell, L Porter, G G Giles, M R E McCredie, J L Hopper, D J Venter, BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. British Journal of Cancer. ,vol. 79, pp. 34- 39 ,(1999) , 10.1038/SJ.BJC.6690008
Melissa C. Southey, Leigh E. Batten, Margaret R. E. McCredie, Graham G. Giles, Deon J. Venter, Gillian Dite, John L. Hopper, Estrogen Receptor Polymorphism at Codon 325 and Risk of Breast Cancer in Women Before Age Forty Journal of the National Cancer Institute. ,vol. 90, pp. 532- 536 ,(1998) , 10.1093/JNCI/90.7.532
Amanda B Spurdle, John L Hopper, Gillian S Dite, Xiaoqing Chen, Jisheng Cui, Margaret RE McCredie, Graham G Giles, Melissa C Southey, Deon J Venter, Douglas F Easton, Georgia Chenevix-Trench, CYP17 Promoter Polymorphism and Breast Cancer in Australian Women Under Age Forty Years Journal of the National Cancer Institute. ,vol. 92, pp. 1674- 1681 ,(2000) , 10.1093/JNCI/92.20.1674
A Jõers, A Kristjuhan, L Kadaja, T Maimets, Tumour associated mutants of p53 can inhibit transcriptional activity of p53 without heterooligomerization Oncogene. ,vol. 17, pp. 2351- 2358 ,(1998) , 10.1038/SJ.ONC.1202146